TKI sensitivity patterns of novel kinase-domain mutations suggest therapeutic opportunities for patients with resistant ALK+ tumors.
Oncotarget
; 7(17): 23715-29, 2016 Apr 26.
Article
in En
| MEDLINE
| ID: mdl-27009859
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Protein-Tyrosine Kinases
/
Oncogene Proteins, Fusion
/
Receptor Protein-Tyrosine Kinases
/
Carcinoma, Non-Small-Cell Lung
/
Drug Resistance, Neoplasm
/
Protein Kinase Inhibitors
/
Lung Neoplasms
/
Mutation
Type of study:
Diagnostic_studies
Limits:
Humans
Language:
En
Journal:
Oncotarget
Year:
2016
Document type:
Article
Affiliation country:
United States
Country of publication:
United States